Philip Kremer

7PUBLICATIONS
40CO-AUTHORS
Gene and molecular therapyVirologyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 14, 2026
Preclinical and clinical investigation of VES001, an oral small molecule sortilin receptor inhibitor for the treatment of frontotemporal dementia: a first-in-human randomized placebo-controlled phase 1 trial.

|Apr 30, 2026
First-In-Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT-02 Freebase, a CNS-Penetrant NLRP3 Inhibitor.

|Feb 18, 2026
Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635.

Geraldine Gontier, Grace Kim, Chao Wang

|Sep 19, 2025
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience.

Juliette A van den Noort, Marella C E van Ruissen, Lisanne C A Smidt

|Jun 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial.

Pepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio

|May 07, 2024
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients.

Eva Thijssen, Bert Tuk, Michel Cakici

Pageof 2

Frequent Collaborators

2 joint publications

Eva Thijssen

2 joint publications

Lisanne C A Smidt

2 joint publications

Matthijs Moerland

2 joint publications

Manon A A Jansen